|
Insider Trading: Zonagen Inc
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Zonagen Inc in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Zonagen Inc since year 2005. Table 2 shows the detailed insider transactions of Zonagen Inc since 2005.
The reporting company's ticker symbol is RPRX.
The reporting company's CIK number is 897075.
The total value of stock buying since 2005 is $35,235,687.
The total value of stock sales is $2,783,355.
The total value of stock exercises is $0.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Zonagen Inc (RPRX) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 09 10 -
Figure 2. Average prices of insider buys, sales, and option exercises at Zonagen Inc (RPRX) in the past 24 months. See table 2 for insider transaction details.
11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 09 10 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Zonagen Inc (RPRX).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-10 | 3,724,508 | 24,213,858 | 0 | 0 | 0 | 0 |
| 2008-05 | 1,600 | 14,742 | 0 | 0 | 0 | 0 |
| 2008-04 | 6,000 | 52,677 | 0 | 0 | 0 | 0 |
| 2008-03 | 125,000 | 1,065,406 | 302,057 | 2,783,355 | 0 | 0 |
| 2008-02 | 51,000 | 423,797 | 0 | 0 | 0 | 0 |
| 2008-01 | 35,500 | 320,365 | 0 | 0 | 0 | 0 |
| 2007-12 | 691,600 | 6,257,755 | 0 | 0 | 0 | 0 |
| 2007-10 | 218,000 | 2,711,683 | 0 | 0 | 0 | 0 |
| 2007-01 | 2,000 | 24,400 | 0 | 0 | 0 | 0 |
| 2006-12 | 6,980 | 45,951 | 0 | 0 | 0 | 0 |
| 2006-11 | 4,025 | 25,045 | 0 | 0 | 0 | 0 |
| 2006-10 | 2,000 | 16,357 | 0 | 0 | 0 | 0 |
| 2006-07 | 3,000 | 24,629 | 0 | 0 | 0 | 0 |
| 2006-05 | 1,000 | 10,990 | 0 | 0 | 0 | 0 |
| 2006-01 | 700 | 3,486 | 0 | 0 | 0 | 0 |
| 2005-04 | 2,425 | 7,067 | 0 | 0 | 0 | 0 |
| 2005-03 | 5,500 | 17,479 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for Zonagen Inc (RPRX)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-10-07 | Podolski Joseph (President and CEO) | Purchase | 4,400 | 7.16 | 31,504 |
| 2008-10-07 | Ploth Louis Jr (VP & Chief Financial Officer) | Purchase | 2,800 | 7.09 | 19,852 |
| 2008-10-02 | Lappe Mark (Director) | Purchase | 1,846,154 | 6.50 | 12,000,001 |
| 2008-10-02 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Purchase | 1,846,154 | 6.50 | 12,000,001 |
| 2008-10-02 | Reed John C (Director) | Purchase | 25,000 | 6.50 | 162,500 |
| 2008-05-23 | Harder Jeffrey R (Director) | Purchase | 1,000 | 9.14 | 9,140 |
| 2008-05-20 | Fourcroy Jean L Md Phd Mph (Director) | Purchase | 600 | 9.34 | 5,602 |
| 2008-04-22 | Ploth Louis Jr (VP & Chief Financial Officer) | Purchase | 500 | 8.77 | 4,385 |
| 2008-04-16 | Podolski Joseph (President and CEO) | Purchase | 1,500 | 8.86 | 13,291 |
| 2008-04-16 | Ploth Louis Jr (VP & Chief Financial Officer) | Purchase | 2,000 | 8.75 | 17,505 |
| 2008-04-15 | Harder Jeffrey R (Director) | Purchase | 1,000 | 8.50 | 8,500 |
| 2008-04-09 | Podolski Joseph (President and CEO) | Purchase | 1,000 | 9.00 | 8,996 |
| 2008-03-27 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Sale | 55,800 | 9.55 | 532,890 |
| 2008-03-26 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Sale | 10,000 | 9.82 | 98,200 |
| 2008-03-25 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Sale | 60,000 | 9.58 | 574,800 |
| 2008-03-24 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Sale | 50,000 | 9.61 | 480,500 |
| 2008-03-20 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Sale | 34,000 | 8.94 | 303,960 |
| 2008-03-18 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Sale | 10,600 | 8.90 | 94,340 |
| 2008-03-17 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Sale | 55,357 | 8.54 | 472,748 |
| 2008-03-14 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Sale | 26,300 | 8.59 | 225,917 |
| 2008-03-12 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Purchase | 50,000 | 8.50 | 425,000 |
| 2008-03-10 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Purchase | 40,000 | 8.46 | 338,400 |
| 2008-03-07 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Purchase | 34,500 | 8.63 | 297,735 |
| 2008-03-03 | Harder Jeffrey R (Director) | Purchase | 500 | 8.54 | 4,271 |
| 2008-02-29 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Purchase | 30,000 | 8.27 | 248,100 |
| 2008-02-28 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Purchase | 20,000 | 8.35 | 167,000 |
| 2008-02-26 | Harder Jeffrey R (Director) | Purchase | 500 | 8.80 | 4,397 |
| 2008-02-04 | Masterson Nola E (Director) | Purchase | 500 | 8.60 | 4,300 |
| 2008-01-24 | Harder Jeffrey R (Director) | Purchase | 1,000 | 8.90 | 8,905 |
| 2008-01-07 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Purchase | 19,500 | 9.08 | 177,060 |
| 2008-01-04 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Purchase | 15,000 | 8.96 | 134,400 |
| 2007-12-31 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Purchase | 54,100 | 9.43 | 510,163 |
| 2007-12-31 | Podolski Joseph (President and CEO) | Purchase | 1,000 | 9.36 | 9,360 |
| 2007-12-28 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Purchase | 70,000 | 9.32 | 652,400 |
| 2007-12-21 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Purchase | 40,000 | 9.38 | 375,200 |
| 2007-12-20 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Purchase | 60,000 | 9.49 | 569,400 |
| 2007-12-19 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Purchase | 43,500 | 9.84 | 428,040 |
| 2007-12-18 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Purchase | 42,100 | 9.79 | 412,158 |
| 2007-12-14 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Purchase | 120,000 | 9.78 | 1,173,600 |
| 2007-12-13 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Purchase | 40,100 | 8.70 | 348,870 |
| 2007-12-06 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Purchase | 60,000 | 7.96 | 477,600 |
| 2007-12-05 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Purchase | 39,300 | 8.18 | 321,474 |
| 2007-12-04 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Purchase | 50,000 | 8.35 | 417,500 |
| 2007-12-03 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Purchase | 71,500 | 7.86 | 561,990 |
| 2007-10-25 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Purchase | 17,000 | 12.69 | 215,713 |
| 2007-10-25 | Podolski Joseph (President and CEO) | Purchase | 1,000 | 12.66 | 12,660 |
| 2007-10-24 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Purchase | 25,000 | 12.55 | 313,725 |
| 2007-10-23 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Purchase | 25,000 | 12.53 | 313,350 |
| 2007-10-22 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Purchase | 25,000 | 12.18 | 304,550 |
| 2007-10-19 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Purchase | 40,500 | 12.34 | 499,608 |
| 2007-10-18 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Purchase | 21,900 | 12.48 | 273,333 |
| 2007-10-17 | Efficacy Biotech Master Fund Ltd. (10% Owner) | Purchase | 62,600 | 12.44 | 778,744 |
| 2007-01-11 | Van As Andre Md, Phd (Chief Medical Officer) | Purchase | 2,000 | 12.20 | 24,400 |
| 2006-12-26 | Van As Andre Md, Phd (Chief Medical Officer) | Purchase | 410 | 11.85 | 4,858 |
| 2006-12-19 | Van As Andre Md, Phd (Chief Medical Officer) | Purchase | 2,000 | 7.08 | 14,160 |
| 2006-12-01 | Harder Jeffrey R (Director) | Purchase | 2,000 | 5.88 | 11,770 |
| 2006-12-01 | Podolski Joseph (President and CEO) | Purchase | 1,500 | 5.90 | 8,850 |
| 2006-12-01 | Ploth Louis Jr (VP & Chief Financial Officer) | Purchase | 1,070 | 5.90 | 6,313 |
| 2006-11-28 | Ploth Louis Jr (VP & Chief Financial Officer) | Purchase | 1,000 | 5.72 | 5,720 |
| 2006-11-27 | Masterson Nola E (Director) | Purchase | 100 | 5.59 | 559 |
| 2006-11-14 | Podolski Joseph (President and CEO) | Purchase | 2,000 | 5.71 | 11,417 |
| 2006-11-01 | Ploth Louis Jr (VP & Chief Financial Officer) | Purchase | 925 | 7.95 | 7,349 |
| 2006-10-27 | Podolski Joseph (President and CEO) | Purchase | 2,000 | 8.18 | 16,357 |
| 2006-07-27 | Cain Daniel F (Director) | Purchase | 2,000 | 8.34 | 16,680 |
| 2006-07-06 | Harder Jeffrey R (Director) | Purchase | 1,000 | 7.95 | 7,949 |
| 2006-05-05 | Podolski Joseph (President and CEO) | Purchase | 1,000 | 10.99 | 10,990 |
| 2006-01-03 | Podolski Joseph (President and CEO) | Purchase | 700 | 4.98 | 3,486 |
| 2005-04-05 | Podolski Joseph (President and CEO) | Purchase | 2,000 | 2.90 | 5,800 |
| 2005-04-05 | Ploth Louis Jr (Chief Financial Officer) | Purchase | 425 | 2.98 | 1,267 |
| 2005-03-21 | Ploth Louis Jr (Chief Financial Officer) | Purchase | 2,500 | 3.10 | 7,750 |
| 2005-03-09 | Podolski Joseph (President and CEO) | Purchase | 3,000 | 3.24 | 9,729 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Zonagen Inc (symbol RPRX,
CIK number 897075) see
the Securities and Exchange Commission (SEC) website.
|
|
